MERTK and neoplasm: In vivo subcutaneous implantation also demonstrated that tumors injected with PROS1‐overexpressing K1 cells were significantly larger than those in the NC group, with MERTK knockdown in K1 cells reducing the tumor growth driven by PROS1 overexpression (Figure S5D).